Health
Results: 709-720 of 9504

Alcohol industry demonstrates near universal compliance with the Portman Group’s health labelling guidelines

AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Acute Treatment of Migraine in Adults

Greywolf Therapeutics reports durable clinical responses with first-in-class oral ERAP1 inhibitor GRWD5769 across six solid tumor types




